Thirona
About Thirona
Thirona is an innovative Dutch MedTech company specializing in artificial intelligence (AI) for medical image analysis, aiming to bridge the gap between academic advancements and clinical application. For physicians, Thirona offers cutting-edge software solutions that provide precise and efficient quantification of medical images, primarily focusing on thoracic CT scans (LungQ™), chest X-rays (CAD4TB), and retinal images (RetCAD™). These AI-powered tools assist healthcare professionals in the detection, evaluation, and treatment planning of various lung diseases, including COPD, asthma, lung cancer, cystic fibrosis, and pulmonary hypertension, as well as ophthalmic conditions like diabetic retinopathy.
The company’s technology empowers earlier and more accurate diagnoses, contributes to personalized treatment strategies, and streamlines workflows for clinicians. Thirona’s LungQ™ platform, for instance, provides reproducible CT values for pulmonary tissue, essential for quantitative support in diagnosis, patient selection for treatment, and follow-up examinations. Thirona also supports pharmaceutical companies and research institutions by accelerating imaging-based respiratory clinical trials and advancing minimally invasive interventions, with its solutions validated in numerous peer-reviewed publications.
Thirona operates under ISO 13485 certification and is compliant with the EU’s Medical Device Regulation (MDR), ensuring high standards of quality and regulatory adherence for its clinically proven AI software, which is utilized in hundreds of hospitals worldwide.
Focus Areas
Business Intelligence
| Key Investors | European Innovation Council (EIC), Borski Fund, HERAN Partners, MannKind Corporation |
| Partnerships | Blackford, Voiant, VIDA Diagnostics, Avicenna.AI, Radboud University Medical Center (RUMC), ScreenPoint Medical |
| Acquisitions | Divestment of Thirona Retina B.V. to Revenio Group's subsidiary Icare Finland Oy in August 2024 |
| Technology | LungQ (modular AI technology for thoracic CT analysis, including advanced segmentation and quantification capabilities, deep learning models), CAD4TB (AI for chest X-rays) |
| FDA Clearances | Multiple (at least 4 versions of LungQ: v3.0.0, v3.1.0, v3.y.z, v4) cleared products (estimated) |
What Physicians Need to Know
For physicians, Thirona's AI-powered LungQu00ae software offers objective, reproducible, and highly accurate insights into lung anatomy and disease progression, moving beyond subjective visual assessments. This leads to enhanced diagnostic accuracy, earlier detection of subtle abnormalities, and more precise patient phenotyping for truly personalized treatment planning. The automated analysis significantly reduces the time and expertise required for complex image interpretation, such as in Cystic Fibrosis, allowing for faster clinical decision-making and improved patient monitoring. Furthermore, for interventional pulmonologists, the software acts as a 'map' for lung anatomy, providing critical 3D visualization and real-time guidance for bronchoscopic procedures, which can increase diagnostic yield and enable more tissue-sparing interventions.
Thirona's LungQu00ae software is designed for flexible integration, available via AI marketplaces or distribution platforms, and can also function as a stand-alone web-based solution. They actively pursue strategic partnerships, such as with VIDA Diagnostics and Avicenna.AI, to expand their capabilities and facilitate seamless access to their advanced AI-powered lung analyses within existing clinical trial services and diagnostic workflows.
What the Web Says
Thirona is an innovative Dutch MedTech company specializing in AI for medical image analysis, particularly for CT scans of the lungs and retinal fundus images. Their products, like LungQu2122 and RetCADu2122, aim to improve patient outcomes, streamline workflows for clinicians, and support research in areas such as COPD, asthma, lung cancer, and diabetic retinopathy. The company has received FDA clearance for its LungQu2122 software and is actively involved in international clinical trials and research collaborations. While specific reviews for Thirona on platforms like G2, Glassdoor, Capterra, and Reddit were not directly found, general sentiment around similar healthcare IT and AI-powered solutions on these platforms tends to be positive regarding efficiency and support, with some concerns about initial setup and user interface.
Overall: MixedStrengths
- AI-powered for high-precision quantitative analysis of medical images, especially lung CT scans.
- Products like LungQu2122 aim to improve patient outcomes and streamline clinician workflows.
- LungQu2122 software has received FDA clearance, indicating regulatory approval and reliability.
- Actively supports international clinical trials and research collaborations.
- Focuses on bridging the gap between academic theory and clinical application with intuitive products.
- Strong emphasis on scientific excellence and collaboration within a research-driven environment.
Limitations
- Specific product and employer reviews for Thirona were not readily available on major review platforms like G2, Glassdoor, Capterra, or Reddit.
- General challenges in similar software include potential for complex initial setup and configuration.
- Some AI-powered platforms can have a learning curve for users not accustomed to the technology.
- Lack of direct reviews makes it difficult to assess specific user experience or employer sentiment for Thirona.
- Potential for extra costs if content usage exceeds agreed limits in some platforms.
Based on reviews from: G2, Glassdoor, Capterra, Google Search (healthcare IT reviewers, company information), Reddit
Last updated: 2026-07-19
Videos
News, demos, and interviews about Thirona.
Videos load interactively. If none appear, search YouTube for Thirona →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Thirona.
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

